Coeptis Therapeutics Holdings, Inc.

NasdaqCM:COEP Stock Report

Market Cap: US$102.1m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Coeptis Therapeutics Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of COEP?
Owner TypeNumber of SharesOwnership Percentage
Private Companies24,1100.387%
Public Companies50,0000.803%
Institutions562,5559.04%
Individual Insiders896,00614.4%
General Public4,690,55075.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 84.9%.

Top Shareholders

Top 25 shareholders own 24.63% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.93%
Christopher Calise
368,741US$6.0m17.9%no data
5.46%
The Vanguard Group, Inc.
339,486US$5.6m570%no data
5.31%
David Mehalick
330,192US$5.4m154%no data
1.52%
Armistice Capital LLC
94,774US$1.6m0%0.04%
1.13%
Daniel Yerace
70,531US$1.2m54.9%no data
1.03%
Christine Sheehy
64,031US$1.1m26.7%no data
0.8%
Purple Biotech Ltd
50,000US$820.0k0%no data
0.68%
Geode Capital Management, LLC
42,097US$690.4k12.6%no data
0.43%
State Street Global Advisors, Inc.
26,830US$440.0k35%no data
0.39%
AMLS Holdings, Inc.
24,110US$395.4k0%no data
0.36%
Brian Cogley
22,500US$369.0k0%no data
0.29%
Marshall Wace LLP
18,192US$298.3k0%no data
0.22%
BlackRock, Inc.
13,566US$222.5k0%no data
0.21%
Eugene Salkind
13,161US$215.8k213%no data
0.2%
Northern Trust Global Investments
12,219US$200.4k0%no data
0.14%
Philippe Deschamps
8,950US$146.8k0%no data
0.14%
Christopher Cochran
8,950US$146.8k0%no data
0.14%
Tara DeSilva
8,950US$146.8k0%no data
0.11%
Anchor Investment Management, LLC
7,000US$114.8k0%0.01%
0.08%
Steward Partners Investment Advisory, LLC
5,000US$82.0k100%no data
0.044%
FMR LLC
2,718US$44.6k121%no data
0.0038%
The PNC Financial Services Group, Inc.
238US$3.9k-48.6%no data
0.0032%
Morgan Stanley
200US$3.3k0%no data
0.0031%
UBS Asset Management AG
193US$3.2k0%no data
0.0016%
Osaic Advisory Services, LLC
100US$1.6k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/27 12:32
End of Day Share Price 2026/04/24 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Coeptis Therapeutics Holdings, Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael KingD. Boral Capital LLC.
Aydin HuseynovLadenburg Thalmann & Company